A Novel Recurrent 200 kb CRYL1 Deletion Underlies DFNB1A Hearing Loss in Patients from Northwestern Spain
Genes · 2025
DOI: 10.3390/genes16060670 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes, 2025. Verfasst von Guadalupe A Cifuentes und 13 weiteren Autor:innen. Beteiligte Einrichtung: Fundación Centro Médico de Asturias, 33193 Oviedo, Spain. Hauptthemen laut MEDLINE: Connexin 26, Hearing Loss, Sensorineural, Sequence Deletion. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundación María Cristina Masaveu Peterson.
Abstract (Originalsprache)
Background/Objectives: Pathogenic recessive GJB2 variants are the main genetic cause of non-syndromic sensorineural hearing loss. However, following GJB2 testing, a significant proportion of deaf patients are only found to be heterozygous carriers of pathogenic GJB2 alleles. Five large deletions not affecting GJB2 but encompassing a minimal common 62 kb region within the neighbouring CRYL1 gene have been described to cause loss of cis GJB2 expression and, as a result, produce hearing loss when in trans with pathogenic GJB2 variants. We describe the identification and characterization of a novel deletion of this type in deaf patients from northwestern Spain.
Methods
We used panel NGS sequencing to detect the deletion, MLPA to validate it, whole-genome sequencing to map its breakpoints, PCR + Sanger sequencing to finely characterize it and triple-primer PCR to screen for it.
Results
We identified a novel 200 kb deletion spanning the whole CRYL1 gene in two unrelated deaf patients from Asturias (in northwestern Spain) who were heterozygous for the pathogenic GJB2 c.35delG variant. Although the large deletion was absent from gnomAD v4.1.0 and 2052 local control alleles, screening for it in 20 additional deaf carriers of monoallelic pathogenic GJB2 variants detected it in another patient from Galicia (also in northwestern Spain). The novel deletion, termed del(200 kb)insATTATA, explained hearing loss in 3/43 (7%) deaf patients from our cohort that were otherwise heterozygous for pathogenic GJB2 variants.
Conclusions
This work highlights the importance of comprehensively testing all genomic regions known to be clinically relevant for a given genetic condition, including thorough CRYL1 CNV screening for DFNB1A diagnostics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Fundación Centro Médico de Asturias, 33193 Oviedo, Spain.
- Instituto de Medicina Oncológica y Molecular de Asturias (IMOMA), 33193 Oviedo, Spain.
- Hospital Centro Médico de Asturias, 33193 Oviedo, Spain.
- Institute of Molecular Oncology and Functional Genomics, School of Medicine, Technische Universität München, 81675 Munich, Germany.
- Hospital Universitario Central de Asturias, 33011 Oviedo, Spain.
- Cabanillas Precision Consulting, 8620 Zürich, Switzerland.
ORCID-Profile: Guadalupe A Cifuentes, Raquel Capín, Adrián Santiago, Juan Cadiñanos
Förderung
- Fundación María Cristina Masaveu Peterson
Zitieren
APA
Cifuentes, G. A., Diñeiro, M., Huete, A. R., Capín, R., Santiago, A., Vargas, A. A. R., Carrero, D., Martínez, E. L., Aguiar, B., Fischer, A., Rad, R., Costales, M., Cabanillas, R., & Cadiñanos, J. (2025). A Novel Recurrent 200 kb CRYL1 Deletion Underlies DFNB1A Hearing Loss in Patients from Northwestern Spain. Genes. https://doi.org/10.3390/genes16060670
Vancouver
Cifuentes GA, Diñeiro M, Huete AR, Capín R, Santiago A, Vargas AAR, et al. A Novel Recurrent 200 kb CRYL1 Deletion Underlies DFNB1A Hearing Loss in Patients from Northwestern Spain. Genes. 2025. doi:10.3390/genes16060670
BibTeX
@article{Cifuentes2025,
author = {Cifuentes, Guadalupe A and Diñeiro, Marta and Huete, Alicia R and Capín, Raquel and Santiago, Adrián and Vargas, Alberto A R and Carrero, Dido and Martínez, Esther López and Aguiar, Beatriz and Fischer, Anja and Rad, Roland and Costales, María and Cabanillas, Rubén and Cadiñanos, Juan},
title = {A Novel Recurrent 200 kb CRYL1 Deletion Underlies DFNB1A Hearing Loss in Patients from Northwestern Spain},
journal = {Genes},
year = {2025},
doi = {10.3390/genes16060670}
}
EUVIMED